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Study of five penicillinase producing 
Neisseria gonorrhoeae isolated in Italy
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Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
Five penicillinase producing Neisseria gonorrhoeae (PPNG) were isolated from urethral specimens of men admit-
ted to the “Santa Chiara” Hospital (Trento, Italy). All strains proved to be resistant to penicillin and ampicillin, and
sensitive to cefuroxime, erythromycin, tetracycline, spectinomycin, nalidixic acid and ciprofloxacin. PPNG plas-
mid profiles showed that four of the isolates carried the 3.2 MDa “Africa” plasmid and one the 4.5 MDa “Asia” plas-
mid, the two well-known phenotypes reported in the USA and Europe as well as in Asian and African countries.
Membrane matings were performed using N. gonorrhoeae carrying the 24.5 MDa conjugative plasmid as donors
and E. coli K12 J 53 as recipient. The transfer of β-lactamic antibiotic resistance was supported by the presence
of 4.5 or 3.2 MDa plasmid bands and by β-lactamase production in the transconjugants. Restriction analysis of
Asian and African plasmids is reported.
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INTRODUCTION
Gonorrhoea is a common transmissible bacter-
ial infection, and WHO (1999) estimates place
the yearly number of new gonococcal infections
worldwide at nearly 60 million. Gonorrhoea
begins as an infection of the superficial mucous
membranes (Brown, 1999), such as those of the
endocervix, urethra, pharynx or rectum (LiMaye,
2003). Approximately 10-20% of infected women
develop salpingitis, with resultant tubal scarring
and either infertility or ectopic pregnancy
(Westrom and Eschenbach, 1999; Zhu et al.,
2004). Many cases are asymptomatic and there-
fore remain undiagnosed. Untreated or inade-
quately treated gonococcal infections may have
repercussions such as blood dissemination
(LiMaye, 2003) and spread to other people.
Neisseria gonorrhoeae has developed chromoso-
mal and plasmid resistance to several antibiotics,
and the number of penicillinase-producing N. gon-
orrhoeae (PPNG) increased rapidly from 1987 to
1991 (Fox et al., 1997), slightly falling off when
penicillin therapy against gonorrhoea was dis-
continued (Lind, 1997). It has been suggested that
the decrease of PPNGs is due to the therapeutic
use of active drugs other than penicillins and to
the use of fluoroquinolones, which can attack β-
lactamase plasmids (Kam et al., 1995). 
Penicillinase-producing N. gonorrhoeae carrying
the Asian plasmid (4.4-4.7 MDa) were first iso-
lated in the USA in 1976 (Ashford et al., 1976)
from United States military servicemen who had
relocated from Southeast Asia, and these agents
are named according to their epidemiological ori-
gin in the Far East. The first strains carrying the
African plasmid phenotype (3.2-3.4 MDa) were
instead isolated in the UK in 1976 (Phillips, 1976).
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Two other deletion derivatives were detected in
1984 by separate research groups and designat-
ed Toronto (3.05 MDa) (Yeung et al., 1986) and
Rio plasmids (2.9 MDa) (van Embden et al., 1985).
Other plasmids have been reported, including
Nimes (4.0 MDa) (Gouby et al., 1986), New
Zealand (6.0 MDa) (Brett, 1989) and an unnamed
variant (3.9 MDa) isolated in the Philippines
(Knapp et al., 1997), but global dissemination of
these plasmids has not as yet followed their emer-
gence (Pagotto et al., 2000, Palmer et al., 2000). 
Studies, based on restriction endonuclease,
hybridisation and heteroduplex analysis by
electron microscopy have shown that the African,
Toronto, Nimes, Rio, and New Zealand-type plas-
mids are deletion or insertion derivatives of the
prototype Asian plasmid (Yeung et al., 1986;
Dillon et al.,1989). In particular, the African plas-
mid presents a 2.1 Kb deletion as compared to
the Asian plasmid.
Penicillinase production in these plasmids is
mediated by a TEM1-type β-lactamase encoded
by the Tn2 transposon carried on several relat-
ed plasmids (Palmer et al., 2000) that is cut and
includes 84% of tnpR noncoding sequences, the
entire bla gene, and the right inverted repeat (IR-
R) (Fayet et al., 1982; Pagotto et al., 2000). 
In spite of a worldwide prevalence (Lee et al.,
2000), PPNG strains have rarely been reported
in Italy, probably due to the limited use of peni-
cillin in gonococcal urethritis therapy. The iso-
lation of N. gonorrhoeae less sensitive to penicillin
was first reported up to 1980 (Coppini et al.,
1980). Subsequently, we isolated two PPNG
strains carrying the Asian and African plasmids
(Bondi et al., 1984; Manicardi et al., 1992).
Considering the lack of new reports on PPNG in
Italy, the present work aims to study the plas-
mid phenotypes of five penicillinase-producing
Neisseria gonorrhoeae isolated at the “Santa
Chiara” Hospital of Trento.
MATERIALS AND METHODS
Bacterial strains
The penicillinase producing Neisseria gonorrhoeae
(PPNG) used in this study are listed in Table 1.
The strains were isolated from urethral specimen
of men admitted to the “Santa Chiara” Hospital
(Trento, Italy) and identified by standard bio-
chemical methods (API NH, bioMeriéux, France).
β-lactamase production was assayed using the
chromogenic cephalosporin test (Nitrocefin,
Oxoid, Milano, Italy) (O’Callaghan et al., 1972).
All N. gonorrhoeae were grown on GC agar base
(Oxoid) supplemented with 1% IsoVitalex
(Oxoid) and ampicillin (10 mg/ml, Sigma
Chemical Co. St. Louis, MO, USA), and incubated
for up to 24h at 37°C in a humid atmosphere sup-
plemented with 5% CO
2
.
Determination of minimum inhibitory
concentration
The minimum inhibitory concentration (MIC)
was determined in GC agar base supplemented
with 1% IsoVitalex by breakpoint criteria, as
defined by the National Committee for Clinical
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TABLE 1 - MIC of the five PPNG strains
MIC (µg/ml)
P Ap Cf E Sp T Na Cip
N. gonorrhoeae 57 >128 >128 0,004 0,008 2 1 1 0.25
N. gonorrhoeae 98 >128 >128 0,004 0,016 8 0.06 0.5 0.03
N. gonorrhoeae 157 >128 >128 0,008 0,016 4 1 0.06 0.015
N. gonorrhoeae 237 >128 >128 0,016 0,008 16 0.06 0.5 0.125
N. gonorrhoeae 243 >128 >128 0,008 0,008 1 0.06 0.25 0.03
P = penicillin; Ap = ampicillin; Cf = cefuroxime; E = erythromycin; T = tetracycline; Sp = spectinomycin; 
Na = nalidixic acid; Cip = ciprofloxacin.
Laboratory Standards (NCCLS, 2000). Twofold
serial dilutions of the following antibiotic pow-
ders were tested: ampicillin (Ap), penicillin (P),
cefuroxim (Cf), erythromycin (E), tetracycline (T),
spectinomycin (St), nalidixic acid (Na),
ciprofloxacin (Cip) (all from Sigma).
PPNG plasmid profiles 
Plasmid DNA was isolated by the lyses method
of Birnboim and Doly (1979). Electrophoresis
was conducted on 0.7% agarose, horizontal slab
gels, in TRIS acetate buffer at pH 8.0, using a
steady voltage of 75 V for 120 min. Purified plas-
mids of E. coli V517 (Macrina et al., 1978) were
used as size reference plasmid for molecular
weight determinations.
Conjugation experiments 
Matings were performed by a modified Roberts
and Falkow (1977) method, using the PPNGs car-
rying the 24.5 MDa conjugative plasmid as donors
and E. coli K12 J 53 NaR, ApS as recipient. For
each conjugation, equal volumes of donor and
recipient suspensions were inoculated in 10 ml
of GC broth (Oxoid) with 2 mM CaCl
2
and 2 mM
MgCl
2
added. After overnight incubation at 37°C,
matings were performed on a membrane filter
(0.45 µm-pore-size filter; Millipore Corp.,
Bedford, Mass.) then placed in a GC-agar base
containing Kellogg’s supplement (Difco, Detroit,
MI). After 6 h of further incubation the cells were
resuspended in 2 ml GC broth by vigorous shak-
ing and spread on McConkey agar (Oxoid) sup-
plemented with 10 μg/ml ampicillin and 50 μg/ml
nalidixic acid. The developed colonies were test-
ed for 4.5 and 3.2 MDa plasmid bands and for
β-lactamase activity.
Asian and African plasmids restriction
analysis
Asian and African plasmids were recovered from
agarose gel by the Maniatis technique (Maniatis,
1982). Plasmids were digested with BamHI,
HindIII, PstI according to the manufacture’s
instructions (Promega, Madison, WI). In all analy-
sis lambda phage DNA (Roche Applied Science,
Indianapolis, IN) digested with BamHI, HindIII
and EcoRI (Boehringer, Mannheim, Germany)
was used as molecular size marker. Digests were
separated by electrophoresis on 1% (w/v) agarose
gel in TRIS acetate buffer at pH 8 at 30V for 16h.
RESULTS
Minimum inhibitory concentration
MIC values of PPNGs are reported in Table 1.
All strains were resistant to penicillin and ampi-
cillin (MIC >128 mg/ml), whereas they were sen-
sitive to other antibiotics tested at the follow-
ing MIC ranges: cefuroxime 0.004-0.016 mg/ml,
erythromycin 0.008-0.016 mg/ml, tetracycline
0.06-1 mg/ml, spectinomycin 1-16 mg/ml,
nalidixic acid 0.06 -1 mg/ml, ciprofloxacin
0.0015-0.25 mg/ml.
PPNG and E. coli transconjugant plasmid
profiles 
N. gonorrhoeae 343, 237, 157 and 98 presented
the 3.2 MDa African plasmid and N. gonorrhoeae
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FIGURE 1 - PPNG strains and E. coli NGC Asian
transconjugant plasmid profiles. Lane 1: molecular size
markers prepared from E. coli V517 (35.8, 3.7, 3.4, 2.6,
2.0, 1.8 MDa); lane 2: E. coli NGC 57 Asian transcon-
jugant; lane 3: N. gonorrhoeae 57 with Asian profile;
lanes 4, 5, 6, 7: N. gonorrhoeae 237, N. gonorrhoeae
157, N. gonorrhoeae 343, N. gonorrhoeae 98, all with
African profile.
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57 showed the “Asia” configuration, character-
ized by the 4.5 MDa plasmid. N. gonorrhoeae 157,
98 and 57 harboured the 24.5 MDa conjugative
plasmid. All strains had the 2.6 MDa cryptic plas-
mid. 
African and Asian PPNG strains carrying the 24.5
MDa conjugative plasmid (N. gonorrhoeae 157,
98 and 57) transferred β-lactamic resistance to
E. coli K12 J 53. This transfer was supported by
4.5 or 3.2 MDa plasmid bands observed in the
transconjugants and confirmed by β-lactamase
production. Plasmid profiles of PPNG strains and
E. coli K12 NGC Asia transconjugant are shown
in Figure 1.
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FIGURE 2 - Restriction analysis of N. gonorrhoeae
57 Asian plasmid and N. gonorrhoeae 237 African
plasmid. Lanes 1, 2, 3: Asian plasmid digest with
BamHI and PstI (lane 1), with BamHI and HindIII
(lane 2), with BamHI (lane 3); lanes 4, 5: African plas-
mid digested with BamHI and PstI (lane 4) and with
BamHI (lane 5).
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FIGURE 3 (a, b) - Restriction endonuclease map of the
N. gonorrhoeae 57 Asian plasmid (a) and N. gonor-
rhoeae 237 African plasmid (b). In both plasmids the
PstI site is located in the common region containing
the portion of the Tn2 transposon between the two
BamHI sites, and this explains why two bands with
equal molecular weight are formed. The Asian plasmid,
which shares a region containing a Hind III site was
also cleaved with BamHI and HindIII into three frag-
ments.
a
b
Asian and African plasmids restriction
analysis
Figure 2 illustrates the restriction analysis of 4.5
and 3.2 MDa plasmids. BamHI cleaves the plas-
mids into two characteristic bands (3.16, 1.34
MDa for Asian plasmid and 1.86, 1.34 MDa for
African plasmid), as reported by McNicol et al.,
(1983). Using both BamHI and PstI enzymes,
each plasmid is cleaved into three fragments
(1.86, 0.86, 0.47 MDa for African plasmid and
3.16, 0.86, 0.47 for Asian plasmid). In both plas-
mids, the PstI site is located in the common
region containing the portion of the Tn2 trans-
poson between the two BamHI sites, and this
explains why two bands with equal molecular
weight are formed. The Asian plasmid, which
shares a region containing a HindIII site with
another R factor carried by Haemophilus ducrey
(Brunton et al., 1981), was also cleaved with
BamHI and HindIII into three fragments (2.16,
1.34 and 1.00 MDa) (McNicol et al., 1983). The
plasmidial maps are shown in Figure 3 (a, b).
DISCUSSION
Gonorrhoea remains a major cause of bacterial
sexually transmitted disease (STD) worldwide.
In Africa, for example, N. gonorrhoeae is the most
important cause of male urethritis, and the preva-
lence of gonococcal infection among women is
high, in particular among prostitutes and work-
ers in the sex industry (Germain et al., 1997). The
high prevalence of N. gonorrhoeae in developing
countries is largely related to poor accessibility
to diagnostic tests and appropriate treatments
(Alary et al., 1996). The control of gonococcal
infection is important considering the high inci-
dence of complications. Moreover, gonorrhoea
may play a role in facilitating HIV acquisition
and transmission, due to mucosal inflammation
and greater release of the virus in semen
(Wasserheit, 1992; Bhuiyan et al., 1999).
Antimicrobial resistance among N. gonorrhoeae
isolates in many developing countries has
increased remarkably (Nissinen et al., 1997).
Surveys by the WHO Western Pacific Region in
1997 (WHO, 1998) showed that PPNG was wide-
ly distributed throughout the region. PPNG is
particularly prevalent in the Philippines (81.8%),
Korea (79.3%), Singapore (61%), Vietnam (64%)
and Malaysia (41%). Interestingly, rates are very
low in other countries, such as Japan (2.3%),
Australia (6.4%) and New Zeland (7.4%). The lit-
erature reports high levels of penicillin resistance
that may be a consequence of therapy for unre-
lated illnesses or self-medication with penicillin
or penicillin-related drugs. For this reason the
Centres for Disease Control have recommended
a first-line therapeutic regimen based on fluo-
roquinolones and cephalosporin (CDC, 1993). 
Although in some parts of Europe penicillins are
still used effectively to treat gonorrhoeae, resist-
ance is frequent in imported cases (Tapsall, 2001).
Even in our work the gonococci studied had high
MIC values for penicillin and ampicillin, and con-
sidering the lack of PPNG reports in Italy, these
strains were probably imported. Resistance
was not detected against cefuroxime, erythro-
mycin, tetracycline or nalidixic acid. Our isolates
were also susceptible to spectinomycin and
ciprofloxacin, which remain valuable alternatives
for treating gonorrhoea. 
In our isolates, plasmid analysis showed that four
strains carried the 3.2 MDa “Africa” and only one
the 4.5 MDa “Asia” plasmids, which are respon-
sible for the two well-known phenotypes report-
ed in the USA and Europe as well as in Asian and
African countries. The presence of the 24.5 MDa
conjugative plasmid in both phenotypes suggests
the possibility of a horizontal spread of plasmid-
mediated penicillin resistance. For example, the
host range of an Asia-type plasmid was shown
to include gonococci, members of the family
Enterobacteriaceae and Haemophilus influenzae
(Pagotto and Dillon, 2001). This occurrence is
supported by the transferability of β-lactamic
resistance from PPNG to bacteria belonging to
different genera, as observed for E. coli in our
study. 
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